PNPLA3 and hepatocellular carcinoma: In a sensitivity analysis, an association between the PNPLA3 G/G‐genotype and the risk of both HCC (HR 4.14, 95% CI = 1.43–11.94; aHR 6.46, 95% CI = 1.86–22.44) and liver decompensation (HR 2.58, 95% CI = 1.02–6.56; aHR 2.82, 95% CI = 1.08–7.40) was observed in both unadjusted analysis and adjusted for age, sex, T2D and BMI.